| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0001 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |